X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
AJANTA PHARMA Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA Quarterly Results   (AJPH)

Here are the latest quarterly results of AJANTA PHARMA. For more details, see the AJANTA PHARMA financial fact sheet and AJANTA PHARMA share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

AJANTA PHARMA Quarterly Results

No. of Mths
Qtr. Ending
3
Dec-16
*
3
Mar-17
*
3
Jun-17
*
3
Sep-17
*
3
Dec-17
*
3
Mar-18
*
3
Jun-18
*
3
Sep-18
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m5,3314,7684,7315,4045,8715,3035,1105,441 
Other income Rs m1922448921525281152 
Turnover Rs m5,5234,7924,7795,4966,0225,3565,1915,594 
Expenses Rs m3,5513,1543,4573,5673,8963,9083,5353,779 
Gross profit Rs m1,7801,6141,2751,8371,9751,3951,5751,662 
Depreciation Rs m153189134146150166172175 
Interest Rs m89111121 
Profit before tax Rs m1,8111,4401,1871,7831,9751,2801,4831,638 
Tax Rs m385300239464501335425385 
Profit after tax Rs m1,4261,1409481,3191,4759451,0581,254 
Gross profit margin %33.433.826.934.033.626.330.830.5 
Effective tax rate %21.220.820.226.025.326.228.723.5 
Net profit margin %26.723.920.024.425.117.820.723.0 
Diluted EPS Rs 16.2 13.0 10.8 15.0 16.8 10.7 12.0 14.3  
Diluted EPS (TTM) Rs 56.8 57.6 54.8 55.0 55.5 53.3 54.5 53.8  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: AJANTA PHARMA 2QFY19 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   FULFORD INDIA  ELDER PHARMA  AMAR REMEDIES  J.B.CHEMICALS  DR. REDDYS LAB  

Compare AJANTA PHARMA With:   FULFORD INDIA  ELDER PHARMA  AMAR REMEDIES  J.B.CHEMICALS  DR. REDDYS LAB  

Compare AJANTA PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Of India's Trade Deficit, Etihad Offer for Jet Airways, and Top Cues in Focus Today(Pre-Open)

On Wednesday, share markets in India traded on a volatile note throughout the day and ended on a flat note.The BSE Sensex closed higher by 3 points to end the day at 36321.

Views on news

AJANTA PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 4.9% (Quarterly Result Update)

Nov 6, 2018 | Updated on Nov 6, 2018

For the quarter ended September 2018, AJANTA PHARMA has posted a net profit of Rs 1 bn (down 4.9% YoY). Sales on the other hand came in at Rs 5 bn (up 0.7% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (1QFY19); Net Profit Up 11.6% (Quarterly Result Update)

Aug 1, 2018 | Updated on Aug 1, 2018

For the quarter ended June 2018, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 11.6% YoY). Sales on the other hand came in at Rs 5 bn (up 8.0% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Our First Bluechip Stock Recommendation in Smart Money Secrets(The 5 Minute Wrapup)

Jan 9, 2019

For the first time, we have recommended a bluechip stock in Smart Money Secrets.

3 Stocks in Super Investor Sumeet Nagar's Portfolio That You Can Buy Right Now(The 5 Minute Wrapup)

Jan 11, 2019

The reasons that make these six stocks in Sumeet Nagar's portfolio so compelling

Follow a Super Investor Like This to Multiply Your Wealth(The 5 Minute Wrapup)

Jan 4, 2019

Following a super investor can certainly help build a portfolio and create wealth in the long term.

My First Stock Trading Recommendation For 2019(Profit Hunter)

Jan 10, 2019

My first trading recommendation for 2019 is a bluechip auto stock. Find out everything about it right away.

HDFC Bank Still Going Strong(Chart Of The Day)

Jan 4, 2019

The stock of HDFC Bank has continued to reward shareholders.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

AJANTA PHARMA SHARE PRICE


Jan 16, 2019 (Close)

TRACK AJANTA PHARMA

  • Track your investment in AJANTA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AJANTA PHARMA

AJANTA PHARMA - SANOFI INDIA COMPARISON

COMPARE AJANTA PHARMA WITH

MARKET STATS